View Single Post
Old Sun Dec 8, 2013, 02:04 PM
sbk007 sbk007 is offline
Join Date: Apr 2013
Location: NY
Posts: 322
Thx Birgetta

I think because MDS is so rare there just isn't a lot of incentive monetary wise to get the interest of more scientists and drug companies to focus on it. The drug companies go by revenue per patient, so the population of leukemia patients, and other diseases is much more profitable. Sounds cold but that's the reality of it. You wont hear our President declare a war on MDS anytime soon..Hopefully one of these agents by chance will work for MDS patients.
Reply With Quote